Enlivex Therapeutics fetches $8 mln
Enlivex Therapeutics Ltd, an Israeli clinical stage immunotherapy company, has raised $8 million in financing. The investors were Korea Investment Partners and Hadasit Bio Holdings Ltd.
19 September 2017•1 min read
